Noesis Capital Mangement Corp grew its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 6.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 74,740 shares of the business services provider’s stock after buying an additional 4,650 shares during the quarter. Stericycle makes up about 2.0% of Noesis Capital Mangement Corp’s investment portfolio, making the stock its 23rd largest holding. Noesis Capital Mangement Corp owned approximately 0.09% of Stericycle worth $5,353,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in SRCL. JPMorgan Chase & Co. lifted its holdings in Stericycle by 34.6% in the 1st quarter. JPMorgan Chase & Co. now owns 16,839 shares of the business services provider’s stock worth $1,396,000 after buying an additional 4,331 shares during the period. OppenheimerFunds Inc. lifted its holdings in Stericycle by 1.2% in the 1st quarter. OppenheimerFunds Inc. now owns 5,266 shares of the business services provider’s stock worth $436,000 after buying an additional 60 shares during the period. Wellington Management Group LLP purchased a new position in shares of Stericycle in the 1st quarter valued at approximately $292,000. Teachers Advisors LLC lifted its stake in shares of Stericycle by 6.7% in the 1st quarter. Teachers Advisors LLC now owns 96,652 shares of the business services provider’s stock valued at $8,011,000 after purchasing an additional 6,069 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Stericycle by 55.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 377,242 shares of the business services provider’s stock valued at $31,264,000 after purchasing an additional 134,803 shares during the period. Institutional investors and hedge funds own 94.19% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Stericycle, Inc. (SRCL) Shares Bought by Noesis Capital Mangement Corp” was reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/stericycle-inc-srcl-shares-bought-by-noesis-capital-mangement-corp/1705084.html.

Shares of Stericycle, Inc. (SRCL) traded down $0.52 during trading hours on Wednesday, reaching $63.54. The company’s stock had a trading volume of 1,084,900 shares, compared to its average volume of 819,798. The stock has a market capitalization of $5,468.99, a PE ratio of 14.76, a price-to-earnings-growth ratio of 1.56 and a beta of 0.19. Stericycle, Inc. has a 1-year low of $61.62 and a 1-year high of $88.00. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The company had revenue of $883.00 million for the quarter, compared to analysts’ expectations of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 EPS. sell-side analysts predict that Stericycle, Inc. will post 4.49 EPS for the current fiscal year.

A number of research firms have recently commented on SRCL. Barrington Research lowered their target price on Stericycle from $87.00 to $75.00 and set an “outperform” rating for the company in a research note on Friday, November 10th. BMO Capital Markets lowered their target price on Stericycle from $74.00 to $62.00 and set a “market perform” rating for the company in a research note on Friday, November 10th. Stifel Nicolaus restated a “buy” rating and issued a $85.00 target price (down previously from $95.00) on shares of Stericycle in a research note on Thursday, November 9th. Royal Bank Of Canada lowered their target price on Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a research note on Thursday, November 9th. Finally, Jefferies Group LLC set a $108.00 target price on Stericycle and gave the company a “buy” rating in a research note on Tuesday, October 17th. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $77.17.

In other Stericycle news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction on Monday, November 13th. The stock was sold at an average price of $64.03, for a total transaction of $1,264,784.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.30% of the stock is currently owned by insiders.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.